$BGS

B&G Foods director Brunts buys $18,000 in common stock

B&G Foods director DeAnn L. Brunts bought 5,616.133 shares at $3.2051 each, totaling $18,000. The stock is near its 52-week low after a 34% six-month decline. B&G Foods missed Q2 2026 earnings, reporting $0.06 EPS and $383.3M revenue, below estimates of $0.09 EPS and $395M. The stock rose in after-hours trading.

Original reporting
Published Sep 16, 2026, 9:18 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 1:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$BGS
Neutral
high confidence
Mentioned
$BGS
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BGSNeutralLow
01

Why it matters

The insider purchase adds a minor data point but does not change the overall negative sentiment from the earnings miss.

02

Market read

Limited relevance; the filing is a small insider transaction amid broader earnings disappointment.

03

What to watch

Recent earnings miss and stock proximity to 52‑week low may outweigh any positive signal from the insider buy.

Relevance 4/10Novelty 4/10Timing: post filing Sep 14, 2026

Background

B&G Foods recently reported a Q2 earnings miss, with adjusted EPS of $0.06 versus $0.09 expected, and revenue below forecasts.

Company-level read

Ticker impact

$BGSNeutralHigh confidence
Context

Director DeAnn L. Brunts purchased 5,616 shares of B&G Foods (BGS) for about $18,000, disclosed in a Form 4 filing.

Expected impact

minimal impact; price likely unchanged

Evidence & confidence

The transaction size is trivial relative to market cap and occurs while the stock is near its 52‑week low after a earnings miss.

Market effects

Consumer staples sector may see slight attention to insider activity but no broader impact.

US market only

low

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a bullish signal.

Key entities

  • B&G Foods Inc.

    NASDAQ-listed food products company.

  • DeAnn L. Brunts

    Director of B&G Foods who filed the Form 4 purchase.

Related articles

$BGSMed

Canada watchdog aims to block B&G veg brand disposals to Nortera

Canada's Competition Bureau seeks to block B&G Foods' sale of Green Giant and Le Sieur veg brands to Nortera, citing reduced competition. The bureau argues the deal would lead to higher prices and fewer choices. B&G and Nortera plan to contest the decision. B&G is selling assets to reduce debt. According to the bureau, Nortera is Canada's dominant processor of certain canned and frozen vegetables.

$BGSMedAI 8/10

B&G Foods (BGS) Q2 2026 Earnings Call Transcript

B&G Foods (BGS) reported Q2 2026 net sales of $383.3M, down 9.7% YoY due to divestitures. Adjusted EBITDA rose 4.2% to $60.4M. Net loss narrowed to $4M. Guidance for fiscal 2026 net sales, EBITDA, and EPS was reaffirmed. Management highlighted portfolio reshaping, debt refinancing, and new CEO transition. Risks include inflation, tariffs, and geopolitical tensions.

$BGSMed

BGS Q2 Deep Dive: Portfolio Reshaping and Margin Expansion Take Center Stage

B&G Foods reported Q2 revenue of $383.3M versus $397.3M expected, with adjusted EPS of $0.06 in line. Adjusted EBITDA was $60.39M, slightly above estimates, and operating margin rose to 9%. The company reconfirmed FY revenue guidance of $1.76B and Adjusted EPS of $0.63. CEO Robert Mills highlighted portfolio reshaping, cost cuts, and contract manufacturing.

$BGSMedAI 8/10

B&G Foods Reports Financial Results for Second Quarter 2026

B&G Foods (NYSE: BGS) reported Q2 2026 results including effects of its March 19, 2026 acquisition of College Inn and Kitchen Basics, March 2 Green Giant U.S. frozen divestiture, and a co-manufacturing agreement. Q2 net sales fell to $383.3M from $424.4M. Adjusted EBITDA was $60.4M. Full-year 2026 guidance reaffirmed: net sales $1.735B-$1.775B, adjusted EBITDA $275M-$290M, adjusted EPS $0.575-$0.675.